MAZZEO, Anna
 Distribuzione geografica
Continente #
EU - Europa 13.202
NA - Nord America 10.538
AS - Asia 7.708
SA - Sud America 2.651
AF - Africa 242
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 13
Totale 34.369
Nazione #
US - Stati Uniti d'America 10.302
RU - Federazione Russa 6.529
SG - Singapore 3.630
BR - Brasile 2.252
CN - Cina 1.978
IE - Irlanda 1.705
SE - Svezia 1.166
IT - Italia 947
HK - Hong Kong 781
DE - Germania 711
FI - Finlandia 480
FR - Francia 469
VN - Vietnam 435
UA - Ucraina 405
PL - Polonia 286
GB - Regno Unito 232
IN - India 219
AR - Argentina 154
BD - Bangladesh 93
MX - Messico 92
CA - Canada 88
TR - Turchia 80
ZA - Sudafrica 67
EC - Ecuador 66
IQ - Iraq 65
ID - Indonesia 60
NL - Olanda 54
MA - Marocco 51
UZ - Uzbekistan 47
BE - Belgio 45
CO - Colombia 45
PK - Pakistan 44
JP - Giappone 42
AT - Austria 39
VE - Venezuela 36
CL - Cile 33
ES - Italia 33
CI - Costa d'Avorio 29
PY - Paraguay 25
KE - Kenya 24
PE - Perù 21
AZ - Azerbaigian 20
PH - Filippine 20
SA - Arabia Saudita 19
TN - Tunisia 19
IL - Israele 18
LT - Lituania 17
NP - Nepal 17
AE - Emirati Arabi Uniti 14
CZ - Repubblica Ceca 14
EU - Europa 14
JO - Giordania 14
KZ - Kazakistan 14
AL - Albania 13
DZ - Algeria 12
DO - Repubblica Dominicana 11
KR - Corea 10
RO - Romania 10
TH - Thailandia 10
AU - Australia 9
BO - Bolivia 9
EG - Egitto 9
HN - Honduras 9
KG - Kirghizistan 9
LB - Libano 9
UY - Uruguay 9
JM - Giamaica 8
MY - Malesia 8
RS - Serbia 8
IR - Iran 7
PS - Palestinian Territory 7
GT - Guatemala 6
PA - Panama 6
SK - Slovacchia (Repubblica Slovacca) 6
GA - Gabon 5
GR - Grecia 5
LK - Sri Lanka 5
OM - Oman 5
SN - Senegal 5
AM - Armenia 4
BH - Bahrain 4
CH - Svizzera 4
CR - Costa Rica 4
ET - Etiopia 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
PT - Portogallo 4
AO - Angola 3
BW - Botswana 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
SY - Repubblica araba siriana 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
DM - Dominica 2
HR - Croazia 2
HU - Ungheria 2
LU - Lussemburgo 2
LV - Lettonia 2
LY - Libia 2
Totale 34.333
Città #
Moscow 2.144
Dublin 1.700
Ashburn 1.657
Singapore 1.551
Dallas 1.358
Chandler 1.110
Jacksonville 859
Hong Kong 777
Nyköping 752
Beijing 685
The Dalles 370
Messina 345
San Jose 335
Princeton 299
Munich 292
Warsaw 278
Lauterbourg 277
Medford 270
Los Angeles 248
Cambridge 232
Des Moines 216
Ann Arbor 181
Dearborn 175
São Paulo 156
Ho Chi Minh City 155
Helsinki 149
Buffalo 142
New York 137
Boardman 101
Tianjin 97
Wilmington 78
Turku 75
Guangzhou 72
Council Bluffs 71
Hanoi 71
Rio de Janeiro 70
Redondo Beach 67
San Mateo 67
Orem 66
Jinan 65
Belo Horizonte 60
Shenyang 60
Bremen 52
Pune 47
Brasília 45
Woodbridge 45
Tashkent 44
Hyderabad 43
Santa Clara 43
Chennai 42
Frankfurt am Main 42
Houston 41
Lancaster 41
Shanghai 38
Nanjing 36
Tokyo 36
Curitiba 35
Seattle 33
Shenzhen 33
Brooklyn 32
Ningbo 32
Nuremberg 32
Porto Alegre 32
Hebei 31
Johannesburg 31
Brussels 30
Montreal 30
Zhengzhou 30
Abidjan 29
Hangzhou 29
London 29
San Francisco 29
Chicago 27
Baghdad 26
Guayaquil 26
Mexico City 26
Mumbai 26
Salvador 26
Haikou 25
Lappeenranta 25
Rome 25
Amsterdam 24
Boston 24
Campinas 23
Catania 23
Denver 23
Nairobi 23
Istanbul 22
Jakarta 22
Quito 22
Taizhou 22
Da Nang 21
Dhaka 21
Guarulhos 21
Manchester 21
Milan 21
Norwalk 21
Ribeirão Preto 21
Vienna 21
Baku 20
Totale 19.610
Nome #
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 362
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 326
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 284
Value of 99mTc-DPD scintigraphy as early diagnostic modality in familial amyloidotic polyneuropathy. 272
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 251
Clinical and pathological features of focal myositis 248
A CMT1A PATIENT WITH PAINFUL AND DISABLING SYMPTOMS: FAST RECOVERY AFTER IVIG TREATMENT. 248
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease 240
Etanercept for psoriasis and psoriatic arthritis in a patient with Charcot-Marie-Tooth disease 239
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 230
A Nouvel serum MicroRNA signature to screen ATTR 224
2D Feature Strain Echocardiography in patients with transthyretin familial amyloid plyneuropathy and diffuse cardiac 99mTc-DPD accumulation 219
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 215
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 214
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 210
A family with autosomal dominant mutilating neuropathy not linked to either Charcot-Marie-Tooth disease type 2B (CMT2B) or hereditary sensory neuropathy type I (HSN I) loci 208
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 197
"Dropped- head" syndrome due to isolated myositis of neck extensor muscles: MRI findings 189
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 188
A novel mutation in KIF5A gene causing hereditary spastic paraplegia with axonal neuropathy. 185
Comparison Between 99mTc-Diphosphonate Imaging and MRI With Late Gadolinium Enhancement in Evaluating Cardiac Involvement in Patients With Transthyretin Familial Amyloid Polyneuropathy 180
Behaviour of vinculin and talin in perineurial cells in healthy subjects and in subjects affected by diabteic neuropathy 178
ANT1 is reduced in sporadic inclusion body myositis. 175
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 174
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 173
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 170
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 168
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 168
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 168
A novel Cx32 mutation with unusual phenotype. 167
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 167
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 164
Activation of nuclear factor-kappa B in inflammatory myopathies and Duchenne muscular dystrophy 164
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 164
Is overwork weakness relevant in Charcot-Marie-Tooth disease? 163
Cardiac 99mTc-DPD uptake in subjects with Glu89Gln transthyretin gene mutation: is it the earliest sign of disease development? 162
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 161
Coinvolgimento Cardiaco in Pazienti con Polineuropatia Amiloidotica Familiare: Dimostrazione Precoce con Cardio-Rm 161
Myopathy as the persistently isolated symptomatology of primary autoimmune hypothyroidism 160
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study 157
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation 157
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report 157
Are novel outcome measures for Charcot–Marie–Tooth disease sensitive to change? The 6-minute walk test and StepWatch™ Activity Monitor in a 12-month longitudinal study 156
Parenteral nutrition improves nutritional status, autonomic symptoms and qol in patients with TTR-FAP 156
A NOVEL MUTATION IN KIF5A GENE CAUSING HEREDITARY SPASTIC PARAPLEGIA WITH AXONAL NEUROPATHY; 155
Acquired idiopathic generalized anhidrosis: a case report 154
Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy 153
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study 153
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry 153
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 152
Cardiac involvement in transthyretin familial amyloid polyneuropathy - comparison between 99mTc-DPD SPECT and magnetic resonance imaging 151
Acquired idiopathic generalized anhidrosis: a case report 150
Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis 149
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 147
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 147
A novel Cx32 mutation with unusual phenotype 146
Correlation between semiquantitative analysis of 99mTc-DPD scintigraphy and clinical scores in patients with familial amyloidotic polyneuropathy 146
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis 146
A novel CX32 mutation with unusual phenotype 145
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 145
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial 143
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 143
Mid-basal left ventricular longitudinal dysfunction as a prognostic marker in mutated transthyretin-related cardiac amyloidosis 143
Charcot-Marie-Tooth type X: unusual phenotype of a novel CX32 mutation 142
Activation and localization of transcription factor NF-KB in peripheral neuropathies of different origin. 141
Bilateral symmetrical peroneal neuropathy: rapid recovery after IVIG. 140
Amyloid myopathy presenting with rhabdomyolysis: evidence of complement activation. 139
Atrial function in cardiac amyloidosis: a 2d-strain echocardiography and cardiac MRI study 137
Bilateral symmetrical peroneal neuropathy: rapid recovery after IVIG 136
Amyloid myopathy presenting with rhabdomyolysis 136
Cardiac Involvement in Patients with Family Amyloid Polyneuropathy: Early Demostration with Cardiac Magnetic Resonance 136
Clinical and genotype characteristics and symptom migration in patients with mixed phenotype transthyretin amyloidosis from the transthyretin amyloidosis outcomes survey 135
LOCALIZATION OF VINCULIN AND TALIN AT PERINEURIAL CELLS OF HUMAN SURAL NERVE 135
Atypical rat cerebellar immunoreactivity in a patient with familial amyloid polyneuropathy. 135
AUTONOMIC DYSFUNCTION AND HEART INVOLVEMENT IN TRANSTHYRETIN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY 135
Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer 135
Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association 134
Espressione di ANT1 e attivazione della via RAGE-NF-kB nella miosite a corpi inclusi. 133
Nerve conduction velocity in CMT1A: what else can we tell? 133
Amyloid myopathy presenting with rhabdomyolisis: evidence of complement activation. 132
Behaviour of Vinculin and Talin in Perineurial Cells in Healthy Subjects and in Subjects Affected by Diabetic Neuropathy. 132
Amyloid myopathy presenting with rhabdomyolysis. 131
Facial onset sensory motor neuronopathy: not always a slowly progressive disorder. 130
Quantitative comparison between amyloid deposition detected by 99mTC-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin-related cardiac amyloidosis 130
Atypical rat cerebellar immunoreactivity in a patient with familial amyloid polyneuropathy. 129
Autoimmune polyglandular disease (APECED) and mutineuropathy: a case report 128
A novel CX32 mutation with unusual phenotype 127
Usefulness of Combining Electrocardiographic and Echocardiographic Findings and Brain Natriuretic Peptide in Early Detection of Cardiac Amyloidosis in Subjects With Transthyretin Gene Mutation 127
Early Impairment of Right Ventricular Morphology and Function in Transthyretin-Related Cardiac Amyloidosis 127
Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart 126
Monitoring safety and effectiveness of tafamidis in transthyretin amyloidosis in italy. A 3-year longitudinal multicenter study in a non-endemic area. 126
Dp116, talin, vinculin and vimentin immunoreactivities following nerve transection 125
CMT subtypes in a cohort of italian patients enrolled at Messina neuromuscular centre since 1994 to 2014. 125
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation 125
Acquired idiopathic generalized anhidrosis: a case report. 124
Considerable post-partum worsening in a patient with CMT2E 124
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS). 124
TRANSTHYRETIN AMYLOIDOSIS IN SOUTHERN ITALY POPULATION: DESCRIPTION OF A COHORT OF PATIENTS WITH PHE64LEU MUTATION AND LATE ONSET 123
Late-onset mitochondrial neuromyopathy: an age-related phenomenon ? 123
Dolori muscolari, deficit di forza e/o disturbi sensitivi 123
Totale 16.383
Categoria #
all - tutte 114.492
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.492


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021398 0 0 0 0 0 0 0 0 0 201 130 67
2021/20221.675 25 188 33 85 97 15 135 86 41 95 204 671
2022/20234.505 387 389 219 308 317 415 46 250 2.017 22 102 33
2023/20241.090 79 184 92 73 94 251 26 69 5 72 13 132
2024/20256.750 130 61 95 361 284 315 307 1.288 1.529 336 827 1.217
2025/202616.257 802 1.259 1.504 1.320 1.374 3.566 1.956 1.945 1.928 603 0 0
Totale 34.954